Interpersonal Processes of Care Disparities, Symptom Distress, and Chemotherapy Dosing in Women With Early-Stage Breast Cancer
Open Access
- 10 July 2025
- journal article
- Published by Wolters Kluwer Health in Nursing Research
- Vol. 74 (6) , 416-422
Abstract
Background: Communication is an important tool in combatting racial and economic healthcare disparities in cancer care. The ability to communicate treatment-related distress and troubling symptoms can allow proactive symptom mitigation and adherence to a prescribed cancer treatment. Few studies have explored how racial and economic differences in patient–clinician interactions in cancer care influence symptom distress and chemotherapy adherence. Objectives: This study aimed to examine racial differences in interpersonal processes of care and their association with symptom distress and optimal chemotherapy dose among women diagnosed with early-stage breast cancer (ESBC). Methods: Black and White women newly diagnosed with ESBC and prescribed chemotherapy for a diagnosis of invasive breast cancer were recruited. The Interpersonal Processes of Care Survey and Symptom Distress Scale were included in this analysis. Ratios of prescribed chemotherapy to received chemotherapy were recorded as total chemotherapy percentage. Results: Persons who were Black perceived worse scores in communication, including “lack of clarity,” “discrimination due to race/ethnicity,” and “disrespectful office staff.” Participants who lived in areas of greater deprivation perceived worse levels of “discrimination due to race/ethnicity” compared to those living in areas of less deprivation. Participants who perceived higher “discrimination due to race/ethnicity” were less likely to achieve optimal chemotherapy doses. Those who perceived worse scores for “lack of clarity,” “discrimination due to race/ethnicity,” “disrespectful office staff,” and “compassion” had significantly higher levels of symptom distress. Discussion: Symptom distress during ESBC chemotherapy must be communicated via patient–provider interaction. Patients' perceptions of discrimination and bias may inhibit this process. This interaction requires further interrogation to develop an inclusive symptom communication protocol.Keywords
This publication has 35 references indexed in Scilit:
- The Effect of Race and Area Deprivation on Symptom Profiles Over the Course of Early-Stage Breast CancerJournal of Pain and Symptom Management, 2025
- Neighborhood Disadvantage and Breast Cancer–Specific SurvivalJAMA Network Open, 2023
- Racial Differences in Patient-Reported Symptoms and Adherence to Adjuvant Endocrine Therapy Among Women With Early-Stage, Hormone Receptor–Positive Breast CancerJAMA Network Open, 2022
- Factors associated with symptom distress in women with breast cancer prior to initiation of chemotherapyApplied Nursing Research, 2021
- Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor–Positive Breast Cancer Before Starting ChemotherapyJAMA Network Open, 2021
- Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-AnalysisThe Oncologist, 2021
- Patient-Reported Symptom Severity Among 22,650 Cancer Outpatients in the Last Six Months of LifeJournal of Pain and Symptom Management, 2020
- Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient–provider interactionsBreast Cancer Research and Treatment, 2018
- Patient–physician interaction and quality of life in recently diagnosed breast cancer patientsBreast Cancer Research and Treatment, 2013
- The Development of a Standardized Neighborhood Deprivation IndexJournal of Urban Health, 2006